Life Technology Cell Growth Media

This notice is a combined synopsis/solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 "Streamlined Procedures for Evaluation and solicitation for commercial Items," as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written solicitation will not be issued) and quotes are being requested. The Solicitation number is RFQ-NIAID-1978976 and the solicitation is issued as a Request for Quotes (RFQ).

This acquisition will be processed under FAR Part 13 Simplified Acquisition Procedures (SAP). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) FAC 2019-05 and effective 08/13/2019.

The North American Industry Classification System (NAICS) code for this procurement is 334516, Analytical Laboratory Instrument Manufacturing, the small business size standard of 1000 employees.

This requirement is NOT set-aside for small business.

Background and laboratory needs:
The Vaccine Research Center (VRC) Develops a vaccine against human immunodeficiency virus (HIV); stimulates multi- disciplinary research from basic and clinical immunology and virology through vaccine design and production; integrates modern immunological science with a detailed understanding of the pathogenesis of HIV infection; develops immunogens and vectors and new approaches to vaccination; conducts research directed towards developing candidate HIV vaccines suitable for evaluation in large field trials for efficacy in blocking HIV including both laboratory and clinical research projects focused on developing vaccines to prevent HIV. The Immunology Laboratory (IL) of the VRC Investigates novel aspects of the cellular immune response to pathogens in support of the rational development of a vaccine against HIV; advances current information on ways of manipulating the HIV immune response into practical applications in clinical trials of prophylactic and therapeutic vaccines; and performs detailed analysis of the strength, breadth, plasticity, phenotype, and functional characteristics of the cellular immune response to HIV during natural infection, and determines how it differs from the immune response generated after vaccination. The Biodefense Research Section (BRS) of IL Conducts research on extraordinary biodefense research needs in Ebola and other viral hemorrhagic fevers (VHF) and develops multiple biodefense related vaccine products; studies the innate and adaptive immune response to such agents, and their pathogenetic, viral, cellular, and immune components; utilizes the potential of various animal models to predict pathogenetic and/or immune responses in humans; and develops vaccine products and potential therapeutic agents.

Laboratory needs:
The BRS needs consumable lab supplies to use during sample processing and data collecting and vaccine production. With the constant demand of these items, orders must be in place to provide the lab their essential equipment.
Brand-name Justification:
These labs supplies are on the FDA approved list for this project and is required for the Federal Food and Drug Administration's quarterly testing requirements for human vaccine approval. The brands listed are listed on the in the FDA approved process. Changing the vendor would cost the loss of FDA approval.

This is a standing order, with multiple deliveries.

*Quote Specs:
1. Must be Brand-Name (Life Technologies) Items -see attached spreadsheet
2. Items on quote in same order as our supply listing
3. All delivery/shipping costs included (unknown amount of deliveries)
4. DUNS # and GSA #

ATTENTION OFFERORS!!
*Must include response to FAR Part 52.204-24(c): SEE ATTACHED

Place of Delivery: NIH, 40 Convent Drive, Bethesda, MD 20892

FOB: Destination

Submission shall be received not later than 5:00 p.m. EST, 08/29/2019.

The government intends to award a firm fixed price purchase order to the responsible contractor as a result of this RFQ that will include the terms and conditions set forth herein. The award will be based on the following; price, capability to meet the requirements, delivery and the best value to the government.

The following FAR provisions apply to this acquisition:

FAR 52.212-1 Instructions to Offerors Commercial Items (Oct 2018)

FAR 52.212-3 Offerors Representations and Certifications - Commercial Items (Oct 2018)

Offerors must complete annual representations and certifications on-line at http://www.sam.gov/ in accordance with FAR 52.212-3 Offerors Representations and Certifications- Commercial Items (Please ensure 52.209-2 -- Prohibition on Contracting with Inverted Domestic Corporations--Representation. (Nov 2015) is updated in your SAM record)

FAR 52.203-18 Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements - Representation (Jan 2017)

FAR 52.204-24 Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment (Aug 2019)

The offeror will respond to paragraph (c) of this provision, see attached.

The following FAR contract clauses apply to this acquisition:

FAR 52.204-25 Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment (Aug 2019)

FAR 52-212-4 Contract Terms and Conditions Commercial Items (Oct 2018)

FAR 52-212-5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items (Aug 2019)
*The applicable subparagraphs of FAR52.212-5 are included in the attachment to this posting.
FAR 52.203-19 Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements (Jan 2017)

FAR 52.232-40 Providing Accelerated Payments to Small Business Subcontractors (Dec 2013)

FAR 52.204-19 Incorporation by Reference of Representations and Certifications (Dec 2014)

HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity Investigations (Dec 2015)

By submission of an offer, the offeror acknowledges the requirement that a prospective awardee shall be registered in the System for Award Management (SAM) database prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation (www.sam.gov).

Copies of the above-referenced provisions and clauses are available from http://www.acquisition.gov/far/loadmainre.html & http: //www.hhs.gov/regulation/index.html or, upon request, either by telephone or fax.

Offers may be mailed, e-mailed or faxed to Ms. Skye Duffner, (E-Mail/ skye.duffner@nih.gov 406-802-6092). Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f) (Oct 2018)

All responsible sources may submit an offer that will be considered by this Agency.
Any questions or concerns regarding this solicitation should be forwarded in writing via e-mail to Ms. Skye Duffner at skye.duffner@nih.gov.

.